DepoCyt
Patient Information
PATIENT INFORMATION
Patients should be informed about the expected adverse events of headache, nausea, vomiting, and fever, and about the early signs and symptoms of neurotoxicity. The importance of concurrent dexamethasone administration should be emphasized at the initiation of each cycle of DepoCyt treatment. Patients should be instructed to seek medical attention if signs or symptoms of neurotoxicity develop, or if oral dexamethasone is not well tolerated (see DOSAGE AND ADMINISTRATION).
Brand Name: DepoCyt
Generic Name: Cytarabine Liposome Injection
Generic Name: Cytarabine Liposome Injection
« Previous: DepoCyt - Clinical Pharmacology
Bookmark this page:
WebMD Resources
Cancer and Exercise
Resting to conserve energy may not be the best remedy for fatigue during radiation therapy. See more WebMD Videos »
Cancer
Get the latest treatment options.
DepoCyt
Health Resources
2008 Election & Health Care on WebMD. Get Informed.
Updated & New
RxList does not provide medical advice, diagnosis or treatment.